奥马佐单抗
医学
慢性荨麻疹
嗜酸性粒细胞减少
药品
回顾性队列研究
内科学
免疫球蛋白E
生存分析
肿瘤科
皮肤病科
免疫学
药理学
抗体
作者
Ceyda Tetik Aydoğdu,Emine Neşe Yeniçeri,Suzan Demir Pektaş,Aslan Yürekli,Dilek Daşgın,Ahmed Muayad Jirjees Chakmakchi,İlayda Muslu,Himmet Özdemir,Alp Eren Köroğlu
摘要
Our study aimed to evaluate drug survival after omalizumab treatment by using biomarkers. Our findings suggest that eosinopenia/basopenia may predict shorter omalizumab drug survival, and high baseline total IgE levels are associated with higher relapse rates after treatment cessation in CSU patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI